Showing results (181-190 of 198) with videos related to
Sort By:
Pageof 20
Nature Cancer|December 30, 2022
Targeting T cell checkpoints 41BB and LAG3 and myeloid cell CXCR1/CXCR2 results in antitumor immunity and durable response in pancreatic cancerPat Gulhati, Aislyn Schalck, Shan Jiang, et al.Cancer Cell|March 26, 2019
KRAS-IRF2 Axis Drives Immune Suppression and Immune Therapy Resistance in Colorectal CancerWenting Liao, Michael J Overman, Adam T Boutin, et al.Bioorganic & Medicinal Chemistry Letters|December 16, 2006
Respiratory syncytial virus fusion inhibitors. Part 4: optimization for oral bioavailabilityKuo-Long Yu, Ny Sin, Rita L Civiello, et al.Proceedings of the National Academy of Sciences of the United States of America|October 27, 2017
PAF promotes stemness and radioresistance of glioma stem cellsDerrick Sek Tong Ong, Baoli Hu, Yan Wing Ho, et al.Nature|February 4, 2011
SMAD4-dependent barrier constrains prostate cancer growth and metastatic progressionZhihu Ding, Chang-Jiun Wu, Gerald C Chu, et al.Cancer Discovery|October 11, 2011
PTEN is a major tumor suppressor in pancreatic ductal adenocarcinoma and regulates an NF-κB-cytokine networkHaoqiang Ying, Kutlu G Elpek, Anant Vinjamoori, et al.Nature|August 15, 2014
Oncogene ablation-resistant pancreatic cancer cells depend on mitochondrial functionAndrea Viale, Piergiorgio Pettazzoni, Costas A Lyssiotis, et al.Cell|June 24, 2014
Yap1 activation enables bypass of oncogenic Kras addiction in pancreatic cancerAvnish Kapoor, Wantong Yao, Haoqiang Ying, et al.Frontiers in Physiology|March 27, 2023
Roadmap for an imaging and modelling paediatric study in rural NZHaribalan Kumar, Robby Green, Daniel M Cornfeld, et al.Nature|February 11, 2011
Telomere dysfunction induces metabolic and mitochondrial compromiseErgün Sahin, Simona Colla, Marc Liesa, et al.Pageof 20